Literature DB >> 22049224

Antigens of persistent Chlamydia pneumoniae within coronary atheroma from patients undergoing heart transplantation.

Nicole Borel1, Andreas Pospischil, Robert D Dowling, Claudia Dumrese, Charlotte A Gaydos, Sebastian Bunk, Corinna Hermann, Julio A Ramirez, James T Summersgill.   

Abstract

AIMS: In order for Chlamydia pneumoniae to play a causative role in chronic human disease, it would need to persist within infected tissue for extended periods of time. Current theory suggests that C pneumoniae may persist at the site of infection via an alternative replicative form, known as an aberrant body.
METHODS: A panel of C pneumoniae-specific antibodies upregulated by the aberrant body was used to probe tissue specimens from the coronary atheroma from 13 explanted hearts to identify patterns of reactivity in these tissues, as well as to determine the presence and prevalence of C pneumoniae aberrant bodies.
RESULTS: Six of 13 patients had an ischaemic cardiomyopathy secondary to coronary atherosclerosis, while another six patients had an idiopathic, dilated cardiomyopathy. One additional patient, a young (24 years) woman with cardiomyopathy, had no history of atherosclerotic disease. Eleven patients were positive by immunohistochemistry with at least one antibody. Coronary arteries of the two other patients were negative by immunohistochemistry with all antibodies. One of these patients was the 24-year-old woman with grade I disease and no risk factors for coronary artery disease.
CONCLUSIONS: The protein antigens of persistent C pneumoniae infection found in the atheromatous lesions from patients in this study could potentially be used as markers to detect such infections and some may be virulence factors or immunogens specific to C pneumoniae, thus serving as target molecules for diagnostic use or therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22049224     DOI: 10.1136/jclinpath-2011-200270

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Apolipoprotein A-I inhibits LPS-induced atherosclerosis in ApoE(-/-) mice possibly via activated STAT3-mediated upregulation of tristetraprolin.

Authors:  Kai Yin; Shi-lin Tang; Xiao-hua Yu; Guang-hui Tu; Rong-fang He; Jin-feng Li; Di Xie; Qing-jun Gui; Yu-chang Fu; Zhi-sheng Jiang; Jian Tu; Chao-ke Tang
Journal:  Acta Pharmacol Sin       Date:  2013-04-08       Impact factor: 6.150

2.  The sst1 resistance locus regulates evasion of type I interferon signaling by Chlamydia pneumoniae as a disease tolerance mechanism.

Authors:  Xianbao He; Robert Berland; Samrawit Mekasha; Thomas G Christensen; Joseph Alroy; Igor Kramnik; Robin R Ingalls
Journal:  PLoS Pathog       Date:  2013-08-29       Impact factor: 6.823

Review 3.  Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials.

Authors:  Lee Ann Campbell; Michael E Rosenfeld
Journal:  Front Cell Infect Microbiol       Date:  2014-03-21       Impact factor: 5.293

Review 4.  Laboratory diagnosis of persistent human chlamydial infection.

Authors:  Mirja Puolakkainen
Journal:  Front Cell Infect Microbiol       Date:  2013-12-17       Impact factor: 5.293

5.  Bacterial lipopolysaccharide and antimicrobial LL-37 enhance ICAM-1 expression and NF-κB p65 phosphorylation in senescent endothelial cells.

Authors:  Kaori Suzuki; Mari Ohkuma; Isao Nagaoka
Journal:  Int J Mol Med       Date:  2019-07-31       Impact factor: 4.101

6.  Transcriptional Landscape of Waddlia chondrophila Aberrant Bodies Induced by Iron Starvation.

Authors:  Silvia Ardissone; Aurélie Scherler; Trestan Pillonel; Virginie Martin; Carole Kebbi-Beghdadi; Gilbert Greub
Journal:  Microorganisms       Date:  2020-11-24

Review 7.  Lipopolysaccharides and Cellular Senescence: Involvement in Atherosclerosis.

Authors:  Kaori Suzuki; Etsuo A Susaki; Isao Nagaoka
Journal:  Int J Mol Sci       Date:  2022-09-22       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.